Opportunity Information: Apply for RFA DK 13 022
Apply for RFA DK 13 022
- The National Institutes of Health in the food and nutrition health sector is offering a public funding opportunity titled "Improving Diabetes Management in Young Children with Type 1 Diabetes (DP3)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
- This funding opportunity was created on Aug 9, 2013 and posted on Aug 9, 2013.
- Applicants must submit their applications by Feb 19, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $8,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,400,000.00 in funding.
- Eligible applicants include: Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Small businesses Private institutions of higher education For profit organizations other than small businesses Public and State controlled institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) State governments Public housing authorities/Indian housing authorities County governments City or township governments Native American tribal governments (Federally recognized).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The National Institutes of Health (NIH) funding opportunity RFA-DK-13-022, titled "Improving Diabetes Management in Young Children with Type 1 Diabetes (DP3)," was a discretionary grant program aimed at pushing forward practical, innovative approaches to diabetes care for very young children. The focus was specifically on children age 5 and under who are living with type 1 diabetes, a group with unique medical and day-to-day management challenges because of rapid developmental changes, unpredictable eating and activity patterns, high sensitivity to insulin, and complete reliance on parents or other caregivers for treatment decisions. The central purpose of the announcement was not to fund a large definitive clinical trial right away, but to support the earlier, high-value work needed to build an intervention that is strong enough to justify that next step.
This FOA emphasized development, refinement, and pilot testing of new strategies that could meaningfully improve diabetes management in this age group. In practice, that means applicants were expected to move beyond general ideas and produce an intervention that is well developed and well characterized by the end of the project period. NIH signaled clear end-of-award expectations: the strategy should be demonstrated to be safe for young children, feasible to implement in real-world settings, and acceptable to the families and caregivers who would actually use it. If early findings looked promising, the end product should be positioned to proceed into a larger efficacy trial, with enough preliminary evidence and operational detail (for example, training procedures, delivery methods, adherence supports, outcome measures, and implementation workflow) to make a bigger test realistic and well justified.
The opportunity fell under the NIH activity area connected to Diabetes, Digestive, and Kidney Diseases Extramural Research (CFDA 93.847) and was categorized under Food and Nutrition/Health in the source listing. The funding instrument was a grant, and there was no cost-sharing or matching requirement, which typically makes participation more accessible to academic and community-based applicants that do not have large unrestricted funds.
From a funding standpoint, NIH listed an estimated total funding amount of $8,000,000 for the program, with an award ceiling of $1,400,000 per award. Those figures indicate support for substantial pilot and development work, potentially including multidisciplinary teams, iterative intervention refinement, formative research with families and clinicians, prototype development, and early feasibility testing in relevant care environments.
Eligibility was broad across U.S.-based organizations and included many types of public and private entities. Eligible applicants included public and state-controlled institutions of higher education, private institutions of higher education, nonprofits with or without 501(c)(3) status (as long as they were not institutions of higher education in those specific nonprofit categories), small businesses, for-profit organizations other than small businesses, independent school districts, and a wide range of government entities such as state, county, and city/township governments, as well as special district governments and public housing authorities/Indian housing authorities. Tribal governments and tribal organizations were also eligible, including federally recognized tribal governments and other tribal entities. The announcement explicitly included several institution types commonly highlighted in federal eligibility language, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, and Asian American and Native American Pacific Islander-serving institutions (AANAPISIs), along with faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. At the same time, the FOA clearly excluded foreign participation: non-U.S. entities could not apply, non-U.S. components of U.S. organizations were not eligible, and foreign components as defined by NIH policy were not allowed.
Administratively, the opportunity was posted and created on August 9, 2013, with an original and current closing date of February 19, 2014, and it was later archived on March 22, 2014. The sponsoring agency was NIH, and the announcement provided a standard NIH Office of Extramural Research (OER) contact route for technical issues accessing the announcement or resolving linking problems (FBOWebmaster@OD.NIH.GOV). The full announcement was hosted through the NIH grants guide at the link provided in the source data.
In plain terms, this DP3 FOA was designed to fill the gap between a good idea and a trial-ready program for families of very young children with type 1 diabetes. NIH was looking for teams that could design something new or meaningfully improved, test it in the real world at a small scale, document that it works well enough to be practical and safe, and package it so that a later, larger study could rigorously evaluate whether it improves clinical and family-centered outcomes.
Frequently Asked Questions (FAQs)
What is the name of this NIH funding opportunity?
The opportunity is NIH FOA RFA-DK-13-022, titled "Improving Diabetes Management in Young Children with Type 1 Diabetes (DP3)."
What is the main goal of RFA-DK-13-022 (DP3)?
The goal is to support development, refinement, and pilot testing of practical, innovative approaches to improve diabetes management for very young children with type 1 diabetes. The emphasis is on building an intervention that is sufficiently developed and characterized to justify a later, larger efficacy trial.
Which children are the focus population for this FOA?
This FOA focuses on children age 5 and under who are living with type 1 diabetes.
Why does NIH consider children age 5 and under a unique group for type 1 diabetes management?
The FOA highlights several challenges specific to this age group, including rapid developmental changes, unpredictable eating and activity patterns, high sensitivity to insulin, and full reliance on parents or other caregivers for treatment decisions and day-to-day management.
Is this FOA intended to fund a large definitive clinical trial?
No. The FOA is designed to fund earlier-stage, high-value work needed to create an intervention that is ready to move into a larger efficacy trial, rather than funding a large definitive trial immediately.
What kinds of projects does NIH expect under this DP3 announcement?
NIH expects projects that move beyond general ideas and produce an intervention that is well developed and well characterized by the end of the project period. The FOA emphasizes development, refinement, and pilot testing of new strategies that could meaningfully improve diabetes management in young children.
What end-of-award outcomes does NIH expect from funded projects?
By the end of the project period, NIH expected the strategy to be demonstrated as safe for young children, feasible to implement in real-world settings, and acceptable to families and caregivers who would use it.
What does "feasible to implement in real-world settings" mean in the context of this FOA?
Based on the FOA description, it means the intervention should be practical to deliver outside of a purely theoretical context and workable in relevant care environments, with enough operational detail to support realistic use.
What does NIH mean by "acceptable" to families and caregivers?
The FOA indicates that the intervention should fit the needs and realities of the parents or other caregivers responsible for daily treatment decisions, and it should be acceptable to the families who would actually use it.
If early findings are promising, what should the project be ready to do next?
If early findings are promising, the intervention should be positioned to proceed into a larger efficacy trial, supported by preliminary evidence and clear operational details.
What types of operational details does NIH expect applicants to produce?
The FOA gives examples of the kinds of details that help make a later larger trial realistic, including training procedures, delivery methods, adherence supports, outcome measures, and implementation workflow.
What is the NIH program area and CFDA number associated with this opportunity?
The opportunity falls under Diabetes, Digestive, and Kidney Diseases Extramural Research and is associated with CFDA 93.847.
How was this opportunity categorized in the source listing?
It was categorized under Food and Nutrition/Health.
What is the funding instrument for this FOA?
The funding instrument is a grant.
Is cost sharing or matching required?
No. The FOA states there is no cost-sharing or matching requirement.
How much total funding did NIH estimate for this program?
NIH listed an estimated total funding amount of $8,000,000 for the program.
What is the maximum award amount per award?
The award ceiling listed is $1,400,000 per award.
What kinds of activities could the funding support, based on the FOA description?
The described funding level suggests support for substantial pilot and development work, potentially including multidisciplinary teams, iterative intervention refinement, formative work with families and clinicians, prototype development, and early feasibility testing in relevant care environments.
Which organizations are eligible to apply?
Eligibility is broad across U.S.-based organizations and includes public and state-controlled institutions of higher education, private institutions of higher education, nonprofits with or without 501(c)(3) status (as described in the FOA), small businesses, for-profit organizations other than small businesses, independent school districts, and multiple levels of U.S. government entities.
Are state and local government entities eligible?
Yes. The FOA includes eligibility for state governments, county governments, city or township governments, special district governments, and public housing authorities/Indian housing authorities.
Are Tribal governments and Tribal organizations eligible?
Yes. The FOA includes federally recognized tribal governments and other tribal entities, as well as tribal organizations.
Are U.S. territories or possessions eligible?
Yes. The eligibility language explicitly includes U.S. territories or possessions.
Does the FOA encourage applications from specific types of institutions?
The FOA explicitly includes institution types commonly referenced in federal eligibility language, including HBCUs, Hispanic-serving institutions, TCCUs, Alaska Native and Native Hawaiian-serving institutions, and AANAPISIs, among others.
Are faith-based or community-based organizations eligible?
Yes. The FOA explicitly includes faith-based or community-based organizations.
Are for-profit organizations eligible?
Yes. The eligibility list includes small businesses and for-profit organizations other than small businesses.
Are foreign organizations allowed to apply?
No. The FOA excludes foreign participation: non-U.S. entities cannot apply.
Can a U.S. organization include a non-U.S. component in its application?
No. The FOA states that non-U.S. components of U.S. organizations are not eligible.
Are foreign components permitted under NIH policy for this announcement?
No. The FOA states that foreign components (as defined by NIH policy) are not allowed.
When was this funding opportunity posted?
The opportunity was posted/created on August 9, 2013.
What was the application closing date?
The original and current closing date listed is February 19, 2014.
When was this opportunity archived?
The listing indicates it was archived on March 22, 2014.
Who is the sponsoring agency?
The sponsoring agency is the National Institutes of Health (NIH).
Where was the full announcement hosted?
The full announcement was hosted through the NIH grants guide at the link provided in the source listing.
Who should be contacted for technical issues accessing the announcement or link problems?
The FOA provides an NIH Office of Extramural Research (OER) technical contact route: FBOWebmaster@OD.NIH.GOV.
In plain terms, what gap was this DP3 FOA trying to fill?
It was intended to bridge the gap between a strong idea and a trial-ready program by funding the work needed to design, pilot, and document an intervention so it can realistically advance to a larger efficacy study.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Food and Nutrition Health
Next opportunity: Understanding Barriers and Facilitators to Type 1 Diabetes Management in Adults (DP3)
Previous opportunity: Buffalo Bill Dam
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DK 13 022
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DK 13 022) also looked into and applied for these:
| Funding Opportunity |
|---|
| Understanding Barriers and Facilitators to Type 1 Diabetes Management in Adults (DP3) Apply for RFA DK 13 023 Funding Number: RFA DK 13 023 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $5,000,000 |
| Limited Competition of the MAPP Research Network(U01) Apply for RFA DK 13 507 Funding Number: RFA DK 13 507 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Expansion of the MAPP Research Network (U01) Apply for RFA DK 13 025 Funding Number: RFA DK 13 025 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $250,000 |
| Developmental Centers for Interdisciplinary Research in Benign Urology (P20) Apply for RFA DK 13 019 Funding Number: RFA DK 13 019 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $200,000 |
| Translational Research to Improve Diabetes and Obesity Outcomes (R01) Apply for PA 13 352 Funding Number: PA 13 352 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Harvesting the Neuroimaging Cornucopia for Pancreatic Islet Imaging Reagents for Diabetes Research (DP3) Apply for RFA DK 13 024 Funding Number: RFA DK 13 024 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $300,000 |
| Human Islet Research Network Coordinating Center (U01) Apply for RFA DK 13 013 Funding Number: RFA DK 13 013 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $1,000,000 |
| Human Islet Research Network Bioinformatics Center (U01) Apply for RFA DK 13 014 Funding Number: RFA DK 13 014 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $333,000 |
| Consortium on Targeting And Regeneration (CTAR) HIRN (UC4) Apply for RFA DK 13 015 Funding Number: RFA DK 13 015 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $600,000 |
| Consortium on Human Islet Biomimetics (CHIB) HIRN (UC4) Apply for RFA DK 13 016 Funding Number: RFA DK 13 016 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $1,200,000 |
| Consortium on Modeling Autoimmune Interactions (CMAI) HIRN (UC4) Apply for RFA DK 13 017 Funding Number: RFA DK 13 017 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $600,000 |
| Consortium on Beta cell Death and Survival (CBDS) HIRN (UC4) Apply for RFA DK 13 018 Funding Number: RFA DK 13 018 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $600,000 |
| Evaluating Natural Experiments in Healthcare to Improve Diabetes Prevention and Treatment (R18) Apply for PAR 13 365 Funding Number: PAR 13 365 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $500,000 |
| Pragmatic Research in Healthcare Settings to Improve Diabetes Prevention and Care (R18) Apply for PAR 13 366 Funding Number: PAR 13 366 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $500,000 |
| Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes Prevention and Care (R34) Apply for PAR 13 367 Funding Number: PAR 13 367 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $150,000 |
| Novel Methods for Detection and Measurement of Organ Fibrosis in Kidney, Bone Marrow and Urological Diseases (U01) Apply for RFA DK 13 026 Funding Number: RFA DK 13 026 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $250,000 |
| Biomarkers for Diabetes Complications Non Invasive Measures in the Eye (DP3) Apply for RFA DK 13 027 Funding Number: RFA DK 13 027 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $1,000,000 |
| Limited Competition for the Data Coordinating Center for Type I Diabetes TrialNet (UC4) Apply for RFA DK 13 508 Funding Number: RFA DK 13 508 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| George M. OBrien Urology Cooperative Research Centers Program (U54) Apply for RFA DK 13 020 Funding Number: RFA DK 13 020 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $1,000,000 |
| Seeding Collaborations for Translational Research to Discover and Develop New Therapies for Diseases and Conditions within NIDDKs Mission (Revisions) (R01) Apply for PAR 14 006 Funding Number: PAR 14 006 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $75,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DK 13 022", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.